Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
US Stock Insider Trading | Alphatech Holdings Disclosed Three Insider Transactions on March 9
On March 9, 2026, Alphatec Holdings (ATEC) disclosed three insider transactions. Director Miles Patrick sold 219,700 shares on March 5, 2026.
【Recent Insider Transactions】
【Company Profile】
Alphatec Holdings, Inc. was incorporated in Delaware in March 2005. The company is a medical technology firm dedicated to designing, developing, manufacturing, and selling surgical products for spinal disease treatment, focusing on factors affecting spinal aging. The company offers a comprehensive product portfolio and pipeline addressing cervical and thoracic intervertebral regions, covering various spinal conditions. Its main products target the global orthopedic spinal disease market. The company emphasizes collaboration with spine surgeons to design and co-develop a range of products. It has advanced manufacturing equipment, providing a unique competitive advantage and enabling rapid delivery of solutions to meet urgent needs of doctors and patients. Its products and systems, with enhanced functionality, attract surgeons, offering a complete suite of solutions for safe and successful spinal surgeries. All implants sold in the U.S. are approved by the Food and Drug Administration. The company’s strategic goal is to become a leading independent global spine company focused on solutions for spinal aging. Spinal aging has unique characteristics, and its solutions target patients with osteoporosis, vertebral compression fractures, scoliosis, disc degeneration, or spinal stenosis. To further differentiate its offerings, the company has integrated minimally invasive techniques and biologics into its product portfolio to improve patient outcomes.